These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2226478)

  • 1. European standards for antibiotic susceptibility testing: towards a theoretical consensus.
    Baquero F
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro MIC break point for appropriate clinical use of antibiotic].
    Uete T; Matsuo K
    Jpn J Antibiot; 1993 Mar; 46(3):205-21. PubMed ID: 8510318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):925-30. PubMed ID: 14585864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.
    Dalhoff A; Ambrose PG; Mouton JW
    Infection; 2009 Aug; 37(4):296-305. PubMed ID: 19629383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
    Brown DF; Wootton M; Howe RA
    J Antimicrob Chemother; 2016 Jan; 71(1):3-5. PubMed ID: 26377864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units.
    Hanberger H; Nilsson LE; Claesson B; Kärnell A; Larsson P; Rylander M; Svensson E; Sörberg M; Sörén L
    J Antimicrob Chemother; 1999 Nov; 44(5):611-9. PubMed ID: 10552977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BSAC standardized disc susceptibility testing method (version 10).
    Andrews JM; Howe RA;
    J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who defines resistance? The clinical and economic impact of antimicrobial susceptibility testing breakpoints.
    Jorgensen JH
    Semin Pediatr Infect Dis; 2004 Apr; 15(2):105-8. PubMed ID: 15185194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.
    Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Diaz Hogberg L; Kahlmeter G
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial spectrum of an antibiotic and clinical categorization].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NCCLS in antimicrobial susceptibility testing and monitoring.
    Ginocchio CC
    Am J Health Syst Pharm; 2002 Apr; 59(8 Suppl 3):S7-11. PubMed ID: 11977864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations from MENSURA for selection of antimicrobial agents for susceptibility testing and criteria for the interpretation of antibiograms].
    Rev Esp Quimioter; 2000 Mar; 13(1):73-86. PubMed ID: 10856132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.
    Humphries RM; Abbott AN; Hindler JA
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30971460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance.
    Ringertz S; Olsson-Liljequist B; Kahlmeter G; Kronvall G
    Scand J Infect Dis Suppl; 1997; 105():8-12. PubMed ID: 9435026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms.
    Giani T; Morosini MI; D'Andrea MM; García-Castillo M; Rossolini GM; Cantón R
    Clin Microbiol Infect; 2012 Nov; 18(11):E452-8. PubMed ID: 22909279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?
    Kahlmeter G
    J Antimicrob Chemother; 2015 Sep; 70(9):2427-39. PubMed ID: 26089441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we reevaluate antibiotic breakpoints?
    Ferraro MJ
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
    Bengtsson S; Bjelkenbrant C; Kahlmeter G
    Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revised system for antibiotic sensitivity testing. The Swedish Reference Group for Antibiotics.
    Scand J Infect Dis; 1981; 13(2):148-52. PubMed ID: 7313568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.